Neuronetics: Q1 Earnings Snapshot

May 12, 2022 GMT

MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Thursday reported a loss of $10.8 million in its first quarter.

The Malvern, Pennsylvania-based company said it had a loss of 41 cents per share.

The medical device company focused on psychiatric disorders posted revenue of $14.2 million in the period.

Neuronetics expects full-year revenue in the range of $58 million to $62 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on STIM at